Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

 35.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 48.10p
  • 52 Week Low: 23.25p
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 741,956
  • Market Cap: £127.42m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Christopher Paul Hancock 4,802,352 £1,692,829
Richard John Rees 2,805,902 £989,080
Craig Jonathan Gulliford 1,630,466 £574,739
John Bradshaw 1,371,082 £483,306
David Gerard Woods 440,255 £155,190
Charles Spicer 308,530 £108,757
Ivonne Cantu 125,000 £44,062

Major Shareholders

Notifier** Holding Value*
Canaccord Genuity Group Inc 39,303,064 £13,854,330
Development Bank of Wales plc 14,376,727 £5,067,796
Finance Wales 12,776,727 £4,503,796
Baillie Gifford & Co 12,537,441 £4,419,448
Creo Medical Group EBT 10,000,000 £3,525,000
M&G Investments 9,428,500 £3,323,546
The Capital Group Companies, Inc. 8,816,807 £3,107,924
AXA Framlington Investment Managers 7,992,961 £2,817,519
Hargreave Hale Limited 6,753,632 £2,380,655
Tellworth Investments 5,772,778 £2,034,904
Hoya Corporation 4,799,880 £1,691,958
Jonathan Craton 3,400,294 £1,198,604
Cotterford Co Limited 3,335,398 £1,175,728
Mark Farmer 3,121,607 £1,100,366
RBC Trustees (CI) Ltd 2,974,727 £1,048,591
Angel Co Fund 2,967,120 £1,045,910

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 35.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 48.10p
52 Week Low 23.25p
Volume 741,956
Shares Issued 361.48m
Market Cap £127.42m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.13% below the market average65.13% below the market average65.13% below the market average65.13% below the market average65.13% below the market average
69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average
Price Trend
15.11% above the market average15.11% above the market average15.11% above the market average15.11% above the market average15.11% above the market average
27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average
Income Not Available
Growth
15.65% below the market average15.65% below the market average15.65% below the market average15.65% below the market average15.65% below the market average
27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 28-May-2024

Time Volume / Share Price
16:17 15 @ 35.29p
15:52 1,500 @ 35.29p
15:49 2,000 @ 35.30p
15:06 3,246 @ 35.05p
13:36 5,681 @ 35.20p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page